These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7692899)
1. Autotransfusion of shed blood contributes additionally to blood saving in patients receiving aprotinin (2 million KIU). Schönberger JP; Bredée J; Speekenbrink RG; Everts PA; Wildevuur CR Eur J Cardiothorac Surg; 1993; 7(9):474-7. PubMed ID: 7692899 [TBL] [Abstract][Full Text] [Related]
2. Blood loss and use of blood in internal mammary artery and saphenous vein bypass grafting with and without adding a single, low-dose of aprotinin (2 million units) to the pump prime. Schönberger JP; van Zundert A; Bredée JJ; Gardien M; Everts PA; Bavinck JH; Berreklouw E; Wildevuur CR Acta Anaesthesiol Belg; 1992; 43(3):187-96. PubMed ID: 1280395 [TBL] [Abstract][Full Text] [Related]
3. The use of ultra-low-dose aprotinin to reduce blood loss in cardiac surgery. Alvarez JM; Quiney NF; McMillan D; Joscelyne K; Connelly T; Brady P; Deal C; Wilson R J Cardiothorac Vasc Anesth; 1995 Feb; 9(1):29-33. PubMed ID: 7536481 [TBL] [Abstract][Full Text] [Related]
4. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360 [TBL] [Abstract][Full Text] [Related]
5. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562 [TBL] [Abstract][Full Text] [Related]
6. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages]. Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of a cell saver and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing valve surgery. Tempe DK; Banerjee A; Virmani S; Mehta N; Panwar S; Tomar AS; Ghambeer DK; Nigam M J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):326-30. PubMed ID: 11426363 [TBL] [Abstract][Full Text] [Related]
18. [A comparison of autologous transfusion procedures in hip surgery]. Lorentz A; Osswald PM; Schilling M; Jani L Anaesthesist; 1991 Apr; 40(4):205-13. PubMed ID: 2058822 [TBL] [Abstract][Full Text] [Related]
19. Consistent non-pharmacologic blood conservation in primary and reoperative coronary artery bypass grafting. Ovrum E; Am Holen E; Tangen G Eur J Cardiothorac Surg; 1995; 9(1):30-5. PubMed ID: 7727143 [TBL] [Abstract][Full Text] [Related]
20. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery. Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]